Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Zosano Pharma
company
About
Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.
- 51 - 100
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $14.99M
- Industries
- Biopharma,Biotechnology,Medical
- Founded date
- Oct 1, 2006
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization.It was founded in 2006 and headquartered in Fremont, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$138.02M
Zosano Pharma has raised a total of
$138.02M
in funding over 2 rounds. Their latest funding was raised on
Jun 6, 2015 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 6, 2015 | Post-IPO Debt | $14.99M | 1 |
Hercules Capital
|
— | Detail |
| Sep 19, 2013 | Debt Financing | $3.03M | 1 | — | — | Detail |
| Aug 6, 2009 | Series B | $30M | 1 | — | — | Detail |
| Nov 15, 2007 | Series A | $90M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Zosano Pharma is funded by 3 investors.
Hercules Capital
and Nomura International
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
Nomura International
|
— | Debt Financing |
Phase4 Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
